Product Images Imitrex
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 24 images provide visual information about the product associated with Imitrex NDC 0173-0478 by Glaxosmithkline Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a graph showing the estimated percentage of patients with relief from a placebo and a medication called IMITREX over a period of time in minutes. The x-axis is labeled as time in minutes with data points at 10, 15, 20, and 25 minutes. The y-axis appears to be labeled as the percentage of patients with relief and ranges from 0 to 100 with data points at 0, 20, 40, 60, 80, and 100%. The graph shows that at all time points, significantly more patients taking IMITREX experienced relief than those taking placebo.*
This text seems to be describing a medical product used for carrying and administering medication. It mentions a blue button, syringe cartridges, a cartridge labeled "IMITREX", and a pack for a STATdose Pen. However, there is not enough information to understand the specific use or purpose of this product.*
A tool called Priming Rod is being referred to. However, without additional context, it is unclear what this tool is used for or its specific features.*
This is a description for M Trey Injection, which comes in 2 single-dose syringe cartridges with NDC number 0173-0478-00. The injection is intended for subcutaneous administration only, with a volume of 0.5 ml per dosage. There is not enough information to understand what the injection is used for.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.